Mechanisms of action of hESC-secreted proteins that enhance human and mouse myogenesis. by Yousef, Hanadie et al.
UC Berkeley
UC Berkeley Previously Published Works
Title





























































Adult stem cells persist in the body as we age, but their 
regenerative capacity declines over time, leading to an 
inability of tissues and organs to maintain homeostasis 
and repair damage with advancing age. Old skeletal 
muscle loses its regenerative ability due to the failure of 
satellite cells (muscle stem cells) to divide and generate 
fusion competent myoblasts and terminally 
differentiated myofibers in response to muscle injury or 
attrition [1,2]. Consequentially, the replacement of the 
damaged  tissue  with  new  muscle  fibers  becomes  in- 
 
 









































efficient with age, and instead scarring and 
inflammation persist [3,4]. This age-specific decline in 
myogenic proliferation results from changes in key 
cellular signaling that, in turn, is affected by molecular 
changes in the stem cell niches. Among many other 
changes, decreased Notch and mitogen-activated protein 
kinase (MAPK) pathway signaling, as well as mis-
regulation of the transforming growth factor-β (TGF-β), 
tumor necrosis factor-α (TNF-α), and Wnt pathways, 
have each been shown to underlie the age-specific 
decline in muscle regeneration [1, 2].   
  www.impactaging.com AGING, August 2014, Vol. 6, No 8
Mechanisms of action of hESC-secreted proteins that enhance 






















Here we  extend  these  findings  to  human muscle  progenitors  and  investigate  underlying molecular mechanisms.  Our
results demonstrate that hESC‐conditioned medium enhanced the proliferation of mouse and human muscle progenitors.
Furthermore,  hESC‐produced  factors  activated  MAPK  and  Notch  signaling  in  human  myogenic  progenitors,  and
Delta/Notch‐1  activation  was  dependent  on  MAPK/pERK.  The  Wnt,  TGF‐β  and  BMP/pSmad1,5,8  pathways  were
unresponsive  to hESC‐produced  factors, but BMP  signaling was dependent on  intact MAPK/pERK.  c‐Myc, p57, and p18
were key effectors of the enhanced myogenesis promoted by the hECS factors. To define some of the active ingredients of
the  hESC‐secretome  which  may  have  therapeutic  potential,  a  comparative  proteomic  antibody  array  analysis  was
performed and  identified several putative proteins,  including FGF2, 6 and 19 which as  ligands  for MAPK signaling, were
investigated  in  more  detail.  These  studies  emphasize  that  a  “youthful”  signaling  of  multiple  signaling  pathways  is
responsible for the pro‐regenerative activity of the hESC factors.  
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 Notch activation is a key age-specific determinant of 
satellite cell and myoblast proliferation, and the 
expression of constitutively active Notch-1 enhances the 
proliferation of a variety of myogenic cells and delays 
their differentiation into myofibers during normal adult 
myogenesis by antagonism with Wnt [3-5]. The level of 
Notch-1 activation in response to injury decreases with 
age in satellite cells due to the failure of old damaged 
muscle fibers to up-regulate the Notch-1 ligand Delta 
and forced inhibition of Notch-1 in young muscle 
perturbs the activation of young satellite cells and 
interferes with productive repair of young tissue [6]. In 
agreement with this role of Notch, a conditional knock-
out of RBP-Jκ (one of the main activating / repressing 
target loci of Notch-1-3 signaling [7], diminishes the 
ability of satellite cells to self-renew and promotes their 
precocious differentiation [8, 9]. Interestingly, it has 
also been shown that the crosstalk between the MAPK 
and Notch pathways is essential and evolutionarily 
conserved in the invertebrate embryonic development of 
C. elegans and D. melanogaster, where the MAPK 
pathway positively regulates Delta expression and thus 
subsequent activation of Notch, in a variety of cell-fate 
specification processes [10-12]. Furthermore, some 
evidence also exists for cross-talk between Notch and 
MAPK in developing and postnatal mammalian tissues 
[2, 10-12].  In muscle, once the blockage in the 
activation of aged satellite cells is overcome (for 
example by activation of Notch or by culture in 
mitogenic growth medium), their abilities to form 
myotubes are as robust as those of young cells both in 
vitro and in vivo [3, 6, 13, 14]. 
 
Finally, the bone morphogenetic protein, BMP, 
signaling pathway has been shown to be a critical 
regulator of various embryonic and adult stem cell 
niches [14,15]. BMP is a ligand for the TGF-β protein 
superfamily and its signal transduction operates through 
the Smad1, 5 and 8 transcription factors, which become 
phosphorylated and activated by BMP receptors and 
form heterodimers with constitutively present Smad4. 
Such events promote nuclear translocation of these 
transcriptional regulators causing changes in expression 
of hundreds of down-stream target genes. In addition to 
the canonical Smad signaling, the MAPK pathway can 
also be induced by BMP [15]. In adult myogenesis, BMP 
signaling is upregulated after satellite cell activation both 
in vivo and in vitro, and inhibition of BMP signaling 
promotes myogenic differentiation [16,17]. BMPs may 
promote satellite cell proliferation by activating their 
downstream targets, the differentiation-inhibiting Id 
genes, which inhibit transcription factors that promote 
cell differentiation [17].  
 
Previous studies  have  demonstrated  that  aging  of  the  
stem cell niche is responsible for the decline of tissue 
regeneration and productive homeostasis not only in 
skeletal muscle but also in a variety of postnatal tissues, 
and that old muscle can be rejuvenated to repair almost 
as well as young through several means [4]. These 
findings may prove to be important for the development 
of therapies for age-related tissue degeneration and 
trauma. However, not all of the factors that influence 
the niche are known, and the various physiological 
molecules and balance of signaling crosstalk that 
modulate healthy regeneration are not well established. 
In addition, while numerous approaches have been 
utilized to reverse age-related tissue deterioration in 
murine models, none are suitable for clinical translation. 
As one example, skewing the signaling strength of one 
pathway (either up or down) over a long timespan is 
likely to be deleterious for cells and tissues, potentially 
leading to more cellular dysregulation or oncogenic 
progression [18]. In contrast, modulation of multiple 
interactive signaling pathways to their “youthful” levels 
may have beneficial effects on tissue repair and 
maintenance. 
 
We previously established that hESC-produced proteins 
enhance the regenerative capacity of postnatal and old 
mouse muscle stem/progenitor cells, and that MAPK is 
indispensable for these pro-regenerative effects [14]. 
Furthermore, many FGFs bind heparin [16], and we 
demonstrated that the heparin-binding fraction of the 
hESC-produced factors exert robust proliferative effects 
on mouse muscle progenitor cells and provide a 
rejuvenating stimulus for old murine muscle 
regeneration [17]. Here, we show that hESC-produced 
proteins enhance the regenerative capacity not only of 
mouse but also human muscle progenitor cells, 
determine the molecular mechanisms by which hESC-
produced proteins enhance human myogenic 
proliferation, and establish the molecular identity of 




hESC-produced proteins enhance both mouse and 
human myoblast proliferation  
 
To test the hypothesis that hESC-conditioned medium 
promotes the proliferation and inhibits the 
differentiation of both mouse and human muscle 
progenitor cells, we collected hESC-conditioned 
medium by incubating hESCs overnight in a serum and 
growth factor free medium (Opti-MEM). Primary 
human and mouse myoblasts (muscle progenitor cells) 
were cultured in a 50/50 mixture of low-mitogen 
“differentiation medium” (DMEM with 2% horse 
serum) and hESC-conditioned Opti-MEM, either for 72 
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 hours with daily medium changes (human myoblasts) or 
overnight (mouse myoblasts). We used two assays of 
myogenic regenerative activity: the proliferation of 
human and mouse myoblasts by incorporation of BrdU, 
and their resistance to differentiation in this otherwise 
low-mitogen differentiation medium, as measured by 
expression of embryonic myosin heavy chain (eMyHC). 















































tiation inhibited in both human and mouse muscle 
progenitor cells by the hESC-conditioned medium 
(Figure 1A, B).  Analogously, hESC growth medium 
(mTeSR1) conditioned by hESC culture enhanced 
myoblast proliferation more effectively than mTeSR1 
alone, though mouse myoblasts exhibited significantly 
enhanced proliferation in both media (Supplementary 

















































Figure  1.  Pro‐regenerative  embryonic  factors  that  enhance  human  and mouse myoblast  proliferation  contain  heparin
binding domains.  (A) Primary human or mouse myoblasts were cultured  for 24 hours or 72 hours, respectively,  in 50% differentiation
medium (DMEM, 2% horse serum) plus 50% of the specified medium, with daily medium changes.  A 4 hour or 2 hour BrdU pulse on human
or mouse myoblasts, respectively, was performed before cell fixation to  label proliferating cells.  Immunofluorescence was performed for
eMyHC  (green)  and  BrdU  (red),  with  Hoechst  (blue)  labeling  all  nuclei.  Representative  images  are  shown.  Scale  bar  =  100  µM  (B)




(A), with  the  specified medium. Representative  images  are  shown.  Scale  bar  =  100 µM  (D)  Proliferation  and  differentiation  of  fusion‐
competent human myoblasts were quantified as  in  (B). Results are displayed as  the mean percent of BrdU+ or eMyHC+ proliferating or
differentiating cells +/‐SD, respectively (n=6). Significant differences were identified by Student’s t‐tests (*p<0.004).  
  















































We recently published that in the mouse system, the 
pro-myogenic activity of hESC-conditioned Opti-MEM 
is contained in proteins with heparin-binding activity 
[17]. To explore the evolutionary conservation of this 
phenomenon in a human system, we cultured primary 
human muscle progenitor cells in a 50/50 mixture of the 
low-mitogen differentiation medium plus hESC-
conditioned Opti-MEM that was either complete or 















































Figure 1 (C, D), the proliferation of human myogenic 
cells is greatly enhanced and their differentiation is 
inhibited by the hESC-conditioned Opti-MEM, but this 
pro-myogenic effect is lost when heparin-bound 
proteins are depleted. 
 
To further assess the pro-regenerative activity of hESC-
conditioned medium, we assayed the myogenic 
properties of muscle regenerative cells derived from old 
Figure 2. hESCs secrete pro‐myogenic proteins that act primarily through MAPK signaling. (A) Primary human or
mouse myoblasts were cultured and BrdU pulsed as in Figure 1, with or without 10 μM of a MAPK pathway inhibitor (MEKi),
with daily medium changes, and  immunostained as  in Figure 1. Representative  images are shown. Scale bar = 100 µM.  (B)
Proliferation and differentiation of fusion‐competent myoblasts were quantified as  in Figure 1 (n=4). Significant differences
were  identified by Student’s t‐tests  (*p<0.004  for human cells; *p<2x10‐20  for mouse cells).    (C)  Immunoblotting analysis of
the downstream effector pErk1/2 in the MAPK signaling pathway in human and mouse myoblasts serum starved for one hour
then  treated  for 20 minutes with 50% differentiation medium and 50% of  the  specified medium +/‐ a MEKi  (10 µM).  (D)
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 (2 year) mice, using our published methods [18,20]. 
Gastrocnemius muscles were injured using cardiotoxin 
(CTX), and muscle tissue was collected three days post 
injury. Activated satellite cells associated with muscle 
fibers were plated overnight in a 50/50 mixture of Opti-
MEM and hESC-conditioned Opti-MEM, with 5% old 
serum. In agreement with previously published work 
[14], exposure to hESC-conditioned Opti-MEM more 
than doubled the percentage of BrdU+/Desmin+ old 
activated satellite cells isolated from regenerating 
muscle, bringing them close to the percentage of young 
activated satellite cells (Supplementary Figure 2A, B). 
These data demonstrate that the hESC-conditioned 
Opti-MEM exerts a strong pro-myogenic activity on not 
only mouse but also human muscle progenitor cells, as 
well as positively influences the myogenicity of freshly-
isolated muscle cells that respond to tissue injury, even 
in an old environment or when cultured in old serum 
where their myogenicity is typically suppressed.  
 
Identifying the molecular mechanisms by which 
hESC-produced factors enhance the regenerative 
responses of human and mouse muscle progenitor 
cells  
 
hESC-conditioned medium loses its rejuvenating effect 
on mouse stem and progenitor cells when the MAPK 
pathway is inhibited [14]. Considering the evolutionary 
conservation of the pro-myogenic activity of hESC-
produced proteins between mouse and human, we 
examined the dependence of hESC-produced proteins on 
MAPK in human muscle progenitor cells. With only 2% 
horse serum, differentiation medium is low in mitogens 
and growth factors, and quickly (in 48-72 hours) 
promotes the differentiation of myoblasts into 
multinucleated myotubes. MAPK inhibition, via 
incubation of human muscle progenitor cells for 72 hours 
in a 50/50 mixture of differentiation medium and hESC-
conditioned Opti-MEM along with a mitogen-activated 
protein kinase-kinase inhibitor (MEKi), drastically 
inhibited the proliferation of primary human muscle 
progenitor cells, assayed by a BrdU incorporation pulse 
(Figure 2A, quantified in B), suggesting that the hESC-
produced, pro-regenerative proteins signal through the 
MAPK pathway in human muscle progenitor cells 
(Figure 2A, B). These results are conserved with mouse 
myoblasts and with old mouse muscle regenerative cells, 
as confirmed by incubation of mouse cells in hESC-
conditioned Opti-MEM with or without treatment with 
MEKi (Figure 2A, B, Supplementary Figure 2B, and as 
previously published [14]).  
 
We further pursued the mechanisms by which hESC-
produced proteins enhance the regenerative capacity of 
muscle progenitor cells, with a focus on MAPK 
signaling. Human and mouse muscle progenitor cells 
were serum starved for one hour, followed by a 20 
minute culture in differentiation medium with 50% of 
hESC-conditioned Opti-MEM, hESC-conditioned Opti-
MEM + MEKi, or Opti-MEM conditioned by 
differentiated hESCs as a negative control.  Immuno-
detection by Western blotting was performed on these 
cells, and data were normalized to the levels of 
housekeeping proteins (GAPDH and cytoplasmic β-
actin). The levels of detected phosphorylated-activated 
proteins (for example, pERK1/2) were also normalized 
by the levels of their respective total protein (for 
example total ERK1/2). As shown in Figure 2C 
(quantified in D), hESC-produced factors induced 
higher levels of pERK1 and pERK2 in human and 
mouse muscle progenitor cells, as compared to cells 
cultured in medium conditioned by differentiated 
progeny of hESCs.  As anticipated, MEKi treatment 
down-regulated pERK1 and pERK2. These data suggest 
that proteins produced by hESCs, but not by their 
differentiated progeny, exert a cross-species, conserved 
activation on the MAPK pathway in myogenic cells. 
 
Several signaling pathways (such as TGF-β/pSmad2,3, 
BMP/pSmad1,5,8, canonical Wnt and Delta/Notch), have 
been shown to be crucial for muscle regenerative 
capacity and to be deregulated with age [2]. Western 
blotting analysis as above showed no significant up or 
down-regulation of TGF-β/pSmad2,3, BMP/pSmad1,5,8, 
and canonical Wnt/β-catenin signaling in primary human 
and mouse muscle progenitors upon exposure to the 
hESC-produced factors after 20 minutes or even after 24 
hours (Supplementary Figure 3A, B). In contrast, the 
Notch ligand Delta-1 and truncated/activated Notch-1 
(NICD1) were significantly up-regulated by exposure to 
the hESC-produced proteins, as compared to the 
differentiated progeny of these hESCs that lack pro-
regenerative activity (Figure 3A, quantified in B). Similar 
to MAPK/pERK, the induction of Delta/Notch was 
conserved between human and mouse primary muscle 
progenitors, although in mouse progenitors there was a 
more apparent upregulation of NICD1. As compared to 
mouse cells, basal Notch signaling remained relatively 
high in human muscle progenitors transferred from 
highly mitogenic growth medium into the mitogen-low 
differentiation medium or Opti-MEM, even after serum 
starvation (Supplementary Figure 3C), suggesting that 
Notch-1 that has been activated in growth medium 
persists in human muscle progenitors (Figure 3A, B).  
 
Considering the prominent evolutionary-conserved 
cross talk between MAPK and Notch pathways, we 
examined whether MAPK/pERK signaling is required 
for the activation of the Delta/Notch pathway by the 
hESC-produced factors [3, 6]. Western blotting was 
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 performed on human and mouse muscle progenitors that 
were serum starved for one hour and then exposed for 20 
minutes to hESC-produced proteins in the absence or 
presence of MEKi. As shown in Figure 3A and B, Delta-
1 was up-regulated by the hESC-conditioned medium in 
both human and mouse primary muscle progenitor cells, 
and NICD upregulated in mouse cells, but not when 
MAPK signaling was inhibited. Expression levels of 
Wnt/β-catenin and TGF-β/pSmad2,3 pathway 
components, on the other hand, were not regulated by 













































minute or even 24 hour exposure (Supplementary Figure 
3A, B). Finally, even though BMP/pSmad1,5,8 signaling 
was not activated by the hESC-conditioned medium in 
human or mouse primary muscle progenitors (Figure 3C, 
D), this pathway was dependent on intact MAPK 
signaling in myoblasts of both species: phosphorylation 
of pSmad1,5,8 was significantly down-regulated by the 
MEK inhibitor by 20 minutes of treatment in human and 
mouse cells (Figure 3C, D), and remained inhibited even 
after 24 hours of treatment in human myoblasts (Figure 














































actin  as  loading  controls,  from  human  and mouse myoblasts  serum  starved  for  one  hour  then  treated  for  20 minutes with  50%















































These results suggest that hESC-produced proteins 
enhance the regenerative capacity of postnatal mouse 
and human muscle progenitors by quickly activating 
MAPK/pERK and Delta/Notch signaling, and are 
suggestive of crosstalk between MAPK and Notch 
signaling pathways.  
 
Down-stream effectors of hESC-produced factors in 
primary myogenic human cells  
 
To further understand the mechanisms by which hESC-
produced factors enhance the regenerative responses of 
muscle progenitor cells, gene expression analysis was 
performed on the downstream targets/effectors of the 
above signaling pathways, with a specific focus on the 
regulators of cell cycle progression. Human myoblasts 
were cultured for 72 hours in a 50/50 mixture of 
differentiation medium plus medium conditioned by 
either hESCs or differentiated hESCs, or in 100% of 




































analysis by RT-PCR. As shown in Figure 4A-C, hESC-
produced factors induced expression of c-Myc and down-
regulated the levels of p57 and p18 cyclin dependent 
kinase (CDK) inhibitors. Interestingly, the level of 
another CDK inhibitor p27 was down-regulated by both 
pro-myogenic medium conditioned by hESCs and control 
medium conditioned by their differentiated progeny 
(Figure 4D). However, the expression of an additional 
regulator of cell cycle progression, cdc25a, was not 
influenced by either hESC or differentiated hESC-
conditioned medium (data not shown).  These results 
demonstrate that hESC-produced proteins do not down-
regulate cell cycle inhibitors broadly, but rather influence 
a specific subset of the downstream effectors of cell 
proliferation in human muscle progenitor cells. Con-
sidering that these downstream effectors are direct targets 
of the MAPK/pERK and Delta/Notch pathways, such 
signaling cascades could interact in a combinatorial 
fashion to induce c-Myc and repress p18 and p57 in 
muscle progenitors, promoting their regenerative capacity.  
Figure 4. Expression analysis of MAPK regulated genes. (A‐D) Quantification of downstream CDK inhibitor
expression genes by qRT‐PCR in human myoblasts treated for 72 hours with 50% differentiation medium and 50%
of  the medium specified, with daily medium changes. The  relative expression  level was normalized by GAPDH.






















































































































induced muscle  injury, and cultured overnight  in DMEM/F12 with 10% of old serum and 10 ng/mL FGF 2, 6, 19, or FGFs 6 and 19  in
combination,  followed by a 2 hour BrdU pulse  to  label proliferating  cells before  fixation.  Immunofluorescence was performed with
Desmin (green) and BrdU (red), with Hoechst (blue) labeling all cell nuclei.  Representative images are shown. Scale bar = 100 µM (B)




injury  (Day 5  in  schematic),  and  cultured overnight  in Opti‐MEM with 10% of  their  respective old  serum,  followed by  cell  fixation.
Immunofluorescence was performed with Desmin  (red) and EdU  (green), with Hoechst  (blue)  labeling all cell nuclei.   Representative
images  are  shown  and  demonstrate  that  FGFs  have  a  pro‐myogenic  and  rejuvenating  effect.  Scale  bar  =  100  µM  (E)  Proliferating
myogenic Desmin+/EdU+ satellite cells were quantified by cell  scoring as  in Figure 1.   Results are displayed as  the mean percent of
EdU+/Desmin+ proliferating  satellite  cell  cells +/‐SD  (n=4).  Significant differences were  identified by  Student’s  t  tests  (*p<0.03).  (F)
Cryosections  (10  µm)  of  old  Tibialis  Anterior muscles were  analyzed  by  hematoxylin/eosin  (H&E)  staining  and  immunostaining  for
embryonic myosin heavy chain  (eMyHC, shown  in green). Hoechst stains nuclei  (blue). Scale bars = 100 µM  (G) Regeneration of old

















































Proteomic  analysis of hESC-conditioned Opti-MEM  
 
Considering that medium conditioned by hESCs, but 
not their differentiated progeny, has pro-regenerative 
activity (Figure 1), which is lost upon Proteinase K 
treatment [14, 17], we performed a comparative 
proteomics antibody array analysis of these two media 
(Materials and Methods). Replicate experiments 
indicated specific proteins that were more abundant in 
the hESC-conditioned medium compared with medium 













































candidates are listed in Table 1. Consistently abundant 
were factors that signal through the MAPK, TGF-β, 
Interleukin, and apoptosis pathways (Table 1). Given 
that heparin-binding hESC-produced factors are 
responsible for the pro-myogenic and regenerative 
properties, that FGFs bind heparin [16], and that MAPK 
signaling is crucial for the regenerative effects of hESC-
conditioned medium, from among the growth factors 
and cytokines that were highly up-regulated in the 




Ranking Protein name Function/pathway 
1 FGF Basic Growth factor/ MapK 
2 FGF-19 Growth Factor/ MapK 
3 Angiogenin Ribonuclease, activates ERK 
4 BTC Betacellulin growth factor 
5 IL-13 R alpha 2 Cytokine receptor 
6 Siglec-5/CD170 
Sialic acid IgG like lectin, recruits phosphatases to attenuate 
signaling 
7 IL-15 Cytokine 
8 APJ Apelin receptor, GCPR signals motility 
9 IGFBP-2 Insulin like Growth Factor Binding Protein/ MapK 
10 Chordin-Like 1 TGF-β pathway antagonist 
11 GASP-1 / WFIKKNRP TGF-inhibitor, protease inhibitor, binds myostatin 
12 MFRP Membrane Frizzled related protein, Wnt pathway 
13 IL-10 R alpha Cytokine receptor  
14 Chem R23 Chimerin receptor 23, chemokine 
15 HB-EGF Growth factor/ MapK 
16 FGF-6 Growth factor/ MapK 
17 HGF Hepatocyte Growth Factor-Scatter Factor/ MapK 
18 IL-16 Cytokine 
19 IL-7 R alpha Cytokine receptor 
20 
TRAIL R3 /  
TNFRSF10C 
TNF receptor family, antagonist to apoptosis 
21 BMP-6 TGF-β ligand 
22 IL-1 F9 / IL-1 H1 Cytokine 
23 IL-1 β Cytokine 
24 Kremen-2 Kringle containing membrane protein 2, antagonist to Wnt 
25 
TRAIL R4 / 
TNFRSF10D 
Antagonist to apoptosis 
26 CXCR1 / IL-8 RA Cytokine receptor 
27 Ck β 8-1 / CCL23 Cytokine 
28 β-Catenin Wnt pathway 
29 FGF-13 1B Growth factor/ MapK 
30 TRAIL / TNFSF10 Modulates apoptosis 
31 
CCL14 / HCC-1 / 
HCC-3 
Cytokine 
32 FGF-4 Growth factor/ MapK 
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 hESC candidate  proteins FGF 2, 6, and 19 enhance 
myogenesis and old muscle regeneration  
 
We tested the myogenic effects of fibroblast growth 
factors found to be enriched in hESC-conditioned 
medium, specifically FGF2, 6, and 19, first singly on 
mouse myoblasts in a dose-dependent manner, and then 
in combinations. We assayed cell proliferation (BrdU 
incorporation) and myogenic differentiation (eMyHC+) 
of myoblasts conditioned for 24 hours in low-mitogen 
differentiation medium supplemented with recombinant 
FGF 2, 6, or 19. FGF2 enhanced mouse myoblast 
proliferation in a dose-dependent manner, and FGF6 
also enhanced proliferation but to a lesser degree. 
FGF19 alone, however, had minimal effects on 
proliferation (Supplementary Figure 4A). Furthermore, 
both FGF2 and 6 inhibited differentiation, also in a 
dose-dependent manner (Supplementary Figure 4B). 
FGF19, on the other hand, did not inhibit differentiation 
(Supplementary Figure 4B). It is important to note that 
human FGF19 does not exist in mouse cells, and its 
closest homologue is FGF15 [18]. Curiously, when 
added in combination, FGF6 and 19 were pro-
proliferative and inhibited differentiation to a degree 
similar to that of FGF2 alone (Supplementary Figure 
4C, D). Based on the dosage assays, FGF2-induced 
proliferation was optimal at 30 ng/mL; and the FGF6 
and 19-induced proliferation plateaued at 30 ng/mL  
(Supplementary Figure 4). 
 
























factors on human myoblasts to determine whether their 
activities were evolutionarily conserved. FGF2, 6, and 19 
all induced proliferation of human myoblasts in a dose-
dependent manner (Supplementary Figure 5A, C). 
However, similar to mouse cells, FGF19 did not inhibit 
differentiation, while FGFs 2 and 6 did (Supplementary 
Figure 5B, C). When tested on freshly isolated, injury-
activated old muscle regenerative cells, each exogenous 
FGF individually enhanced and rejuvenated myogenesis, 
based  on  the  numbers  of  newly  generated BrdU+/ 
Desmin+ proliferating muscle progenitors that migrate 
off freshly isolated regenerating old muscle fibers in 
culture (Figure 5A, B). Additionally, while FGF19 had 
very mild effects on primary cultured mouse myoblasts, 
this growth factor displayed a potent pro-regenerative 
activity on freshly isolated muscle stem cells (Figure 5A, 
B). These results suggest that either FGF19 signaling is 
different between the muscle repair cells and their more 
differentiated, cultured progeny, or that a milder 
activation of cell proliferation but without inhibition of 
differentiation, is still effective for the rejuvenation of the 
myogenic capacity of old satellite cells. 
 
When tested in vivo, a mixture of FGF2, 6, and 19 
significantly improved the activation of the aged muscle 
stem cells following injury and rejuvenated the repair of 
old injured skeletal muscle, based on the numbers of 
newly-generated proliferating muscle progenitors at 3 
days post injury and the robust formation of the de-novo 


























Figure  6.  (A) Quiescent  satellite  cells were  isolated  from  uninjured muscle  and  plated  into  quiescent
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 Growth factors are known to enhance proliferation. 
However, the activation of satellite cells requires both 
breakage of quiescence and mitotic promotion, and 
FGF2 alone has been shown to be insufficient to break 
quiescence [17, 19, 20]. To examine any possible 
effects of hESC secreted pro-regenerative factors on 
activation, quiescent satellite cells were isolated from 
uninjured mouse muscle and plated in a low-mitogen 
plating medium, with an equal volume of hESC 
conditioned Opti-MEM or FGFs added in Opti-MEM. 
Typically in vivo and in vitro, satellite cells break 
quiescence and enter S-phase within 30 hours [21] (and 
our unpublished observations).  BrdU was added after 
plating quiescent cells, and 36 hours later the cells were 
fixed for immunoanalysis for myogenicity (desmin) and 
progression through S-phase of cell cycle (BrdU).  In 
hESC-conditioned medium, some myogenic satellite 
cells broke quiescence, and the fraction of cells that 
were activated was relatively high (Figure 6A, B).  
Interestingly, FGF6 and FGF19 also encouraged cells to 
break quiescence, but FGF2 failed to activate satellite 
cells and even appeared to interfere with this effect of 
FGF6 and FGF19 (Figure 6A, B). 
 
These results demonstrate that FGFs 2, 6, and 19 are not 
only enriched in serum-free medium conditioned by the 
hESCs, but are sufficient for pro-myogenic effects in 
mouse and human systems and additionally in their 





Our initial study demonstrated that embryonic stem 
cells produce soluble proteins that robustly enhance 
adult muscle stem cell function even in an aged 
environment, and that production of such proteins is lost 
when these cells differentiate [14, 17]. Furthermore, the 
MAPK pathway was determined to be critical in 
modulating the activity of these embryonic protein(s) 
[14]. These findings are supported by microarray 
analysis conducted on cardiomyocytes subjected to 
hESC-conditioned medium, demonstrating that MAPK 
pathway signaling was among the main induced 
signaling cascades [22].  Here we uncover the 
molecular identity of active hESC-produced proteins 
and demonstrate that specific FGFs are sufficient to 
enhance mouse and human myogenesis.  
 
While FGFs had significant effects on cell proliferation 
of human and mouse myogenic progenitors, antibody 
neutralization of FGF-2, FGF-6 or FGF-19 did not 
significantly reduce the pro-myogenic properties of 
hESC conditioned medium (not shown), suggesting that 
as expected and detected by proteomic antibody array 
(Table 1), many other active growth factors and MAPK 
ligands are secreted by the hESCs. Ultimately, the 
precise molecular definition of most of the pro-
regenerative proteins from the hESC secretome will 
allow one to design optimal therapeutic applications 
with low off-target and side effects.  
 
 Old muscle stem and progenitor cells fail to break 
quiescence and proliferate in response to muscle injury 
largely due to a decrease in physiologic Notch 
signaling, and when down-stream Notch effectors 
become lacking, muscle stem cell prematurely 
differentiate into myofibers, both of which interferes 
with cellular homeostasis and results in scar tissue 
formation rather than newly formed muscle fibers [6]. 
Therefore, the pro-proliferative activities of the heparin-
binding, hESC-secreted factors FGF2, 6, and 19 have 
clear therapeutic potential for enhancing old muscle 
progenitor cell function during muscle injury and repair. 
While FGF2 and 6 were able to promote proliferation 
and inhibit differentiation of human muscle progenitors, 
FGF19 mildly induced proliferation. FGF2 is a well-
known mitogen and critical component of adult and 
embryonic stem cell culture medium [23], and enhances 
the proliferation of already activated myoblasts [17, 24, 
25]. It is also known to promote angiogenesis, 
osteogenesis, wound healing, and tumorigenesis [26, 
27] and to become deregulated in muscle with age [28]. 
FGF6, interestingly, is restricted almost exclusively in 
expression to the myogenic lineage during embryonic 
development, and at high doses FGF6 activates 
proliferation of muscle progenitor cells, while at low 
doses FGF-6 directs cell differentiation [29]. The role of 
FGF-6 in adult myogenesis is much less known, but 
ectopic expression of both FGF-2 and FGF-6 in 
transplanted myoblasts increased their contribution to 
de-novo muscle formation [29, 30]. FGF19, unlike the 
auto-paracrine FGF2 and 6, has both local and systemic 
endocrine effects [18]. FGF19 acts as a hormone to 
regulate nutrient metabolism, it is expressed in both 
neuroectoderm and mesoderm during embryonic 
development, and is known to induce ear formation [31, 
32]. However, a role for FGF19 in muscle regulation 
has not been characterized prior to our work. While 
FGF2 is known primarily to bind FGFR1, FGF6 binds 
FGFR1 and 4, and FGF19 binds FGFR4, and these 
ligands can also induce signaling through other 
somewhat promiscuous FGF receptors [27, 32, 33]. 
Overall, the FGFs thus have complex, multifunctional 
roles in development and tissue regeneration, but we 
just started to uncover their influence on the 
regenerative capacity of adult and old tissue stem cells. 
It will be interesting to find out how differences in 
downstream effectors allow FGF2 and 6 but not FGF19 
to inhibit differentiation and to understand in molecular 
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 terms, how FGF19 exerts its robust positive activity on 
the myogenicity of aged muscle stem cells. While 
FGF2, 6, and 19 were among the most highly 
upregulated by hESCs proteins, it is important to note 
that hESC-produced factors enhanced proliferation and 
inhibited differentiation to a greater extent than FGFs 
added alone or in combination, suggesting that there 
may be other factors in the conditioned medium that 
contribute to the observed rejuvenating effect. 
Deciphering the molecular identity of these boosters of 
tissue repair is our future interesting goal. 
 
While the emerging paradigm is that FGF2 cannot 
promote the breakage of quiescence of muscle stem 
cells [17, 19, 20] , FGF6 and 19 appear to be potent 
inducers of resting satellite cells to enter the cell cycle. 
Since miR-489 has been previously shown to be 
important for the breakage of satellite cell quiescence 
[34], it would be interesting to study whether FGF6 and 
FGF19 induce miR-489 or synergize with its effects. 
Importantly, FGF2 appeared to counteract the positive 
effects of FGF6 and FGF19 on the activation of 
quiescent satellite cells, suggesting an antagonism 
between these ligands, which may manifest through 
cross-talk between receptors, MAPK, AKT/mTOR, or 
other interactive signaling pathways that are known to 
be induced by the FGFs [33, 35].  
 
Further analysis revealed that gene expression, not of 
the traditional CDK inhibitors, but a very specific sub-
set of cell cycle regulators – p18, p57 and c-Myc – 
became altered and are thus likely responsible for 
transducing the pro-regenerative activity of the hESC 
produced proteins. In agreement with our findings, 
these molecules have been demonstrated to act 
downstream of the MAPK, Notch, and TGF-β/BMP 
signaling pathways in other cell types [36, 37]. c-Myc is 
a well-known target of MAPK signaling and inducer of 
proliferation [38, 39]. p18, an INK4 family member, 
suppresses CDK4 or CDK6 during the G1 stage of the 
cell cycle, and inhibits the self-renewal of adult stem 
cells [40]. Therefore, hESC factor-induced down-
regulation of p18 in adult human myogenic progenitors 
may enhance their function by enhancing self-renewal. 
p57, a KIP2 family member, also inhibits proliferation 
by suppressing several G1 cyclin/CDK complexes [41]. 
One characteristic of aged muscle is the up-regulation 
of various CDK inhibitors by increased TGF-β 
signaling with concurrent lack of Notch-1 activation, 
leading to the failure of satellite cells to activate and 
proliferate after muscle injury [42]. hESC-secreted, 
heparin-binding factors can counteract this effect to 
enhance old muscle regeneration [17], and here we now 
show this is mediated through attenuation of specific 
CDK inhibitors via a key evolutionary and 
developmentally conserved signaling cross-talk between 
MAPK and Notch.  
 
One important implication of our work is that 
identifying and reconstructing a “youthful” stem cell 
niche may have long-term beneficial effects on tissue 
regeneration, in contrast to drastic modulation of a 
single cell-fate regulatory pathway, that could have 
deleterious side effects by promoting oncogenic 
transformation and/or inducing cellular senescence [14]. 
In this regard, the composition and concentrations of the 
defined human FGFs that were determined and 
investigated here may be translatable to the clinic and 
yield novel strategies for the enhancement of tissue 
repair in the elderly, ultimately leading to a 
biochemically defined cocktail of physiological 
molecules that is able to delay and even reverse the 




Animals. Young (2-3 month old) and old (22-24 month 
old) C57BL6/J mice were purchased from the Jackson 
Laboratory and the NIH. The animal experimental 
procedures were performed in accordance with the 
Guide for Care and Use of Laboratory Animals of the 
National Institutes of Health, and approved by the 
Office of Laboratory Animal Care, UC Berkeley.  
 
Muscle fibers and muscle stem cell isolation. Injured 
TA muscle was dissected from healthy young and old 
mice and processed to myofibers with associated 
muscle satellite cells by collagenase digestion as 
published [43, 44]. To obtain satellite/myofiber 
associated regenerative cells, myofibers were further 
digested Dispase and Collagenase as published [44].  
 
Cell Culture. Adult human myoblasts were from a 
young adult [14], cultured from passage 10 to 14 in 
Ham’s F-10 (Gibco), 10% Bovine Growth Serum 
(Hyclone), 30 ng/mL FGF2, and 1% penicillin–
streptomycin on Matrigel (BD Biosciences) coated 
plates (1:100 Matrigel:PBS), at 37C and 5% CO2. For 
experimental conditions involving immunostaining, 
human cells were plated at 10,000 cells/well in Matrigel 
coated 8-well chamber slides (1:100 Matrigel: PBS), 
and cultured for 72 hours with daily re-feedings at 37C 
in 10% CO2 incubator prior to fixation with 70% 
ethanol at 4°C. Mouse myoblasts were cultured and 
expanded in mouse growth medium: Ham’s F-10 
(Gibco), 20% Bovine Growth Serum (Hyclone), 5 
ng/mL FGF2 and 1% penicillin–streptomycin on 
Matrigel coated plates (1:300 Matrigel: PBS), at 37°C 
and 5% CO2. For experimental conditions involving 
immunostaining, mouse cells were plated at 40,000 
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 cells/well on Matrigel coated 8-well chamber slides  
(1:100 matrigel: PBS) and cultured for 24 hours at 37°C 
in 10% CO2 incubator prior to fixation with 70% 
ethanol at 4°C. All experiments using a MEK inhibitor 
were treated with 10 µM MEK1/2 Inhibitor (U0126, 
Cell Signaling Technologies). 
 
Human embryonic stem cells (H9 and H7 lines), were 
cultured in mTeSR-1 (Stem Cell Technologies) as 
published [17], and the heparin binding fraction of 
hESC-Conditioned Medium was prepared as published 
[17]. 
 
Cell-Starvation–Mechanism Analysis. Human 
myoblasts were plated at 200,000 cells/well in a 6-well 
plate. Mouse myoblasts were plated at 300,000 
cells/well in a 6-well plate. Plate wells were coated at 
1:100 ECM: PBS. Cells were allowed to stick in human 
growth medium and mouse growth medium, 
respectively, for 1 hour at 5% CO2 at 37°C prior to 2 
washes in serum-free medium (DMEM (Gibco) + 1% 
sodium pyruvate + 1% penicillin streptomycin). Cells 
were then treated 10 seconds in serum-free medium 
with 10μg/mL protamine sulfate for 10 seconds in order 
to remove any remaining bound ligands, followed by 2 
more washes in serum-free medium and a one hour 
incubation in serum-free medium. Cells were then 
treated for 20 minutes in 10% CO2 at 37°C in 50% 
Differentiation Medium (DMEM + 2%HS + 1% 
penicillin streptomycin) and 50% specified medium. 
Cells were washed with PBS and cell lysates collected 
and analyzed for western blot using above mentioned 
western blot analysis method.  
 
Immunocytochemistry and Quantification. Cells were 
fixed with 70% ethanol 30 minutes to overnight before 
3, 5 minute PBS washes, 10 minute 4N HCl treatment, 
permeablization with PBS + 0.25% Triton X-100 for 15 
minutes, 3 PBS washes, and blocking one hour in PBS 
+ 2% FBS. The cells were then incubated with primary 
antibodies overnight at 4C in PBS + 2% FBS. Anti-
eMyHC was from the Developmental Studies 
Hybridoma Bank, Anti-Desmin from Sigma-Aldrich, 
and rat anti-BrdU from Abcam. If stained for EdU (EdU 
Click-It staining kit was from Invitrogen), the HCl 
antibody retrieval method was not performed. Tissue 
sections were fixed with 70% ethanol 30 minutes to 
overnight before 3, 5 minute PBS washes, 2N HCl 
treatment for 20 minutes, permeablization with 0.25% 
Triton-X 100 for 30 minutes, 3 PBS washes followed by 
blocking 1 hour with PBS + 2% FBS. Secondary 
staining with fluorophore-conjugated, species-specific 
antibodies (Donkey anti-Rat-488, #712-485-150; 
Donkey anti-Mouse-488, #715-485-150; Donkey anti-
Rat-Cy3 #712-165-150; or donkey anti-Mouse-Cy3 
#715-165-150; all secondary antibodies from Jackson 
ImmunoResearch). Nuclei were visualized by Hoechst 
stain. For cell quantification, 25-50 20x images per 
replicate were taken on the Molecular Devices 
ImageXpress Micro automated epifluorescence imager, 
followed by automated cell quantification using the 
multiwavelength cell scoring module within the 
MetaXpress analysis software.   
 
Western blotting. Human or mouse primary muscle 
progenitor cells were lysed in RIPA buffer (50 mM Tris, 
150 mM NaCl, 1% NP40, 0.25% sodium deoxycholate 
and 1 mM EDTA, pH 7.4) containing 1X protease 
inhibitor (Roche), 1 mM Phenylmethylsulfonyl fluoride 
(PMSF), 1 mM sodium fluoride and 1 mM sodium 
orthovanadate. Cell lysates were resuspended in 1X 
Laemmli buffer (Bio-Rad), boiled for 5 minutes and 
separated on precast 7.5% or 4-15% TGX gels (Biorad). 
Primary antibodies were diluted in 5% non-fat milk in 
TBS + 0.1% Tween-20, and nitrocellulose membranes 
were incubated with antibody mixtures overnight at 4 °C. 
HRP-conjugated secondary antibodies (Santa Cruz 
Biotech) were diluted 1:1,000 in 5% non-fat milk in TBS 
+ 0.1% Tween-20 and incubated for 1 hour at room 
temperature. Blots were developed using Western 
Lightning ECL reagent (Perkin Elmer), and analyzed 
with Bio-Rad Gel Doc/Chemi Doc Imaging System and 
Quantity One software. Antibodies for phospho-ERK1/2, 
ERK1/2, pSmad1,5,8 and β-Actin, pGSK3β Y216,  and 
Total GSK3β,  were purchased from Cell Signaling. 
pSmad3 was purchased from Epitomics.  Smad2/3, and 
Dll1 antibodies were from Santa Cruz Biotechnology. 
GapDH and Nicd1 antibodies were from Abcam, 
pSmad2 and β-Catenin were from Millipore. 
  
Proteomic analysis. Medium conditioned by hESCs or 
control differentiated hESCs, in duplicate, was labeled 
and hybridized to Raybiotech 507 antibody array slides 
according to the manufacturer’s protocol.  Briefly, 
conditioned Opti-MEM medium containing 
extracellular proteins was dialyzed against phosphate 
buffered saline, biotinylated, dialyzed again, hybridized 
to the array, washed, labeled with streptavidin-Cy3, 
washed, dried and the fluorescent features imaged on a 
Molecular Devices 4000b scanner.  Data were analyzed 
using Genepix and Microsoft Excel software to 
determine relatively enriched signal in the hESC versus 
differentiated samples. 
 
RNA extraction, RT-PCR and real-time PCR. Total 
RNA was extracted from primary human muscle 
progenitor cells using Trizol reagent (Invitrogen) 
according to manufacturer’s instructions. 1 ug of total 
RNA was used for cDNA synthesis with oligo dT 
primers (Invitrogen). For real-time PCR amplification 
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 and quantification of genes of interest, an initial 
amplification using specific primers to each gene of 
interest (realtimeprimers.com) was done with a 
denaturation step at 95°C for 5 min, followed by 40 
cycles of denaturation at 95°C for 1 min, primer 
annealing at 55°C for 30 s, and primer extension at 
72°C for 30 s. Real-time PCR was performed using 
SYBR and an ABI PRISM 7500 Sequence Detection 
System (Applied Biosystems). Reactions were run in 
triplicate in three independent experiments. The 
geometric mean of housekeeping gene GAPDH or β-
Actin was used as an internal control to normalize the 
variability in expression levels and were analyzed using 
the 2 -ΔΔCT method described [45]. 
 
Muscle Injury and In vivo FGF2, 6, and 19 Injection. 
Cardiotoxin injury was as published [46].  FGFs were 
administered to the site of injury at the time of injury 
and again one day later, 5 microliters per site, Opti-
MEM (vehicle), or FGF2, 6, and 19 cocktail (100 
ng/mL in Opti-MEM) at Days 0 and Day 2 for TA, and 
Days 2 and 4 for gastroc (See Figure 5C schematic). 
Mice received intraperitonial injections of EdU (50 
mg/kg) at Day 4 to label proliferating cells, and muscle 
was harvested at Day 5. 
 
Tissue Immunofluorescence and Histological Analysis. 
Histological analysis was as published [10, 13, 47]. 
Cryo-sectioning was performed through the entire 
volume of muscle (typically 50–70 sections total, done 
at 200 μm intervals), thereby serially reconstituting the 
entire tissue, ex vivo.  Regeneration and myogenic 
potential was quantified by examining injury sites from 
representative sections along the muscle (spanning the 
volume of injury), then by measuring the 
injured/regenerating area using Adobe Photoshop 
Elements.  Myofiber regeneration was quantified by 
counting total newly regenerated fibers and dividing by 
the regeneration area.  
 
Quantification and Statistical Analysis. For automated 
quantification of immuno-fluorescent images, 25-100 
20x images per replicate were taken on the Molecular 
Devices ImageXpress Micro automated epifluorescence 
imager, followed by automated cell quantification using 
the multiwavelength cell scoring module within the 
MetaXpress analysis software. Data was analyzed using 
Anova and P values equal or lower than 0.05 were 
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Supplementary  Figure  1.  hESC‐Conditioned  mTeSR‐1,  but  not  mTeSR‐1,  increases  primary  human
myoblast Proliferation and inhibits Differentiation. (A) Primary human myoblasts were cultured for 72 hours
in 50% differentiation medium (DMEM, 2% horse serum) plus 50% of the specified medium.  A 4 hour BrdU pulse









































































































































cells  before  cell  fixation.  Immunofluorescence was  performed with  Desmin  (green)  and  BrdU  (red), with
Hoechst (blue) labeling all cell nuclei. Representative images are shown. Scale bar = 100 µM (B)  Proliferating
Desmin+/BrdU+  satellite  cells were  quantified  by  cell  scoring  in multiple  random  fields  of  each  condition.

































































































































Supplementary  Figure  3.    hESC‐produced  factors  Act
through  MapK  and  BMP  signaling  pathways,  but  not
through  TGF‐β  or  Wnt  Signaling.  Western  immunoblotting
analysis  of  downstream  effectors  of  BMP  and  Wnt  signaling
pathways  in  human  or mouse myoblasts  serum  starved  for  one
hour  followed  by  treatment  for  20 minutes  (A)  or  24  hours  (B)
with 50% Differentiation Medium and 50% Specified Medium +/‐ a
MEKi  (10  µM)  to  analyze  crosstalk  with  MAPK  pathway.  (C)
Western  immunoblotting  analysis  of  active  Notch‐1  in  human
myoblasts  treated  for 20 minutes with  specified medium after 1
hour serum starvation. 
 
Supplementary  Figure  4.  hESC  candidate  factors
FGF2,6,&19  exhibit  a  pro‐myogenic  effect  on  mouse
myoblasts  in a dose dependent manner. Primary mouse
myoblasts  were  cultured  for  24  hours  in  differentiation
medium  (DMEM,  2%  horse  serum)  plus  0,  5,  10,  30  or  100
ng/mL  FGF2,  6,  or  19.    A  2  hour  BrdU  pulse  on  mouse
myoblasts  was  performed  before  cell  fixation  to  label
proliferating  cells.  Immunofluorescence  was  performed  for
eMyHC (green) and BrdU (red), with Hoechst (blue) labeling all
nuclei  (30  ng/ml  images  shown  in  C).  Scale  bar  =  100  µM.
Proliferation  and  differentiation  of  fusion‐competent
myoblasts  were  quantified  as  in  Figure  1,  and  results  are
displayed  as  the mean  percent  of  (A)  BrdU+  or  (B)  eMyHC+
proliferating or  differentiating  cells  +/‐SD,  respectively  (n=6).
(D)  Quantification  of  FGFs  added  individually  at  the
determined optimal dosage  for proliferation  (30 ng/mL) or  in
combination,  as  described  for  (A)  and  (B).  Significant



































label  proliferating  cells.  Immunofluorescence  was  performed  for  eMyHC  (green)  and  BrdU  (red),  with
Hoechst (blue) labeling all nuclei (Images not shown). Proliferation and differentiation of fusion‐competent
myoblasts were quantified as in Figure 1, and results are displayed as the mean percent of (A)  BrdU+ or (B)
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